Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lunardi, C.
Right arrow Articles by Puccetti, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lunardi, C.
Right arrow Articles by Puccetti, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 12, No. 5, 647-657, May 2000
© 2000 Japanese Society for Immunology

Glycine-rich cell wall proteins act as specific antigen targets in autoimmune and food allergic disorders

Claudio Lunardi1, Luca Nanni2, Micaela Tiso4, Maria Cristina Mingari3,4, Caterina Bason4, Mara Oliveri2,4, Beat Keller5, Romano Millo2, Giorgio De Sandre1, Roberto Corrocher1 and Antonio Puccetti2,4

1 Department of Clinical and Experimental Medicine, University of Verona, 37134 Verona, Italy
2 DIMES, Department of Experimental Medicine, and
3 Department of Clinical and Experimental Oncology, University of Genova, 16132 Genova Italy
4 CBA/ABC Advanced Biotechnology Center, 16132 Genova, Italy
5 Institute of Plant Biology, University of Zurich, 8008 Zurich, Switzerland

Correspondence to: A. Puccetti, Unità di Citologia Molecolare–Unità Monoclonali B3, Advanced Biotechnology Center, Largo Rosanna Benzi 10, 16132 Genova, Italy

Our objective was to investigate the presence of a B and T cell immune response directed against the glycine-rich cell wall protein (GRP) in patients with different autoimmune disorders and with food allergy. GRP is an ubiquitous food protein that has high homology with cytokeratins and other self proteins [Epstein–Barr virus nuclear antigen-1 (EBNA-I), heterogeneous nuclear ribonucleoprotein, fibrillar collagen] which are common targets in autoimmune disorders. A peptide (GGYGDGGAHGGGYGG) derived from GRP was used to screen human sera in direct and competitive ELISA assay. Anti-GRP-specific IgG were analyzed for their ability to cross-react with autoantigens. The intracellular cytokine profiles of the peptide-specific T cell clones obtained from representative patients have been studied. BALB/c mice were immunized with the peptide coupled to the carrier protein keyhole limpet hemocyanin (KLH). Serum IgG antibodies directed against the GRP peptide were detected in several autoimmune disorders and in food allergic patients, and were able to cross-react with autoantigens including keratin, collagen and EBNA-I. Twenty-five T cell clones showed a specific proliferative response to the GRP peptide and were of the Th0 phenotype. Eight of the 10 BALB/c mice immunized with the peptide coupled to KLH developed an autoimmune response. Our data suggest that phylogenetically highly conserved epitopes in plants, viruses and humans may be responsible for an autoimmune response in susceptible individuals. They also indicate that the antigen spreading of a particular sequence among apparently divergent proteins may participate to initiate or amplify an immune response.

Keywords: autoantigens, glycine-rich protein, random peptide library

The first two authors contributed equally to this work

Transmitting editor: L. Moretta


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.